-
A somatic reference standard for cancer genome sequencing with COLO829
Study
EGAS00001001385
-
Genomes of Relapsing Neuroblastoma
Study
EGAS00001001387
-
Genome-wide identification of distinct miRNA-mRNA target regulation pairs in Non-Hodgkin lymphomas: a report from the ICGC MMML-Seq consortium
Study
EGAS00001001394
-
Genetic and epigenetic characterization of adenoid cystic carcinoma
Study
EGAS00001001457
-
Exome Sequencing to Define the Landscape of Plasma Cells in Systemic Light chain Amyloidosis
Study
EGAS00001001418
-
Exome-sequencing of human B cell lymphoma cell lines
Study
EGAS00001001463
-
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Study
EGAS00001001479
-
WGS of MAPKi acquired resistant samples from patients and PDX models
Study
EGAS00001006874
-
Transcriptomic analysis of liver CD8+ T cells
Study
EGAS00001006885
-
Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
Study
EGAS00001002571
-
Vitamin C boosts DNA demethylation in TET2 germline mutation carriers
Study
EGAS00001006916
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
Genomic analysis reveals novel secondary drivers and progression pathways in skin basal cell carcinoma
Study
EGAS00001001540
-
Genomic and transcriptomic profiling of signalling networks in follicular lymphoma
Study
EGAS00001002175
-
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
Study
EGAS00001001601
-
Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study
Study
EGAS00001001516
-
Distinct portrayal of lesions in synchronous multifocal lung adenocarcinoma revealed by genome sequencing
Study
EGAS00001001572
-
Container Study for ICGC Malignant Lymphoma Master Study (MMML)
Study
EGAS00001001600
-
The spatial organization of intratumor heterogeneity andevolutionary trajectories of metastases in hepatocellular carcinoma
Study
EGAS00001001603
-
BMP4 and temozolomide synergize in the majority of patient derived glioblastoma cultures
Study
EGAS00001007095
-
Cancer sequencing for somatic variant calling
Study
EGAS00001007101
-
Chondrosarcoma_Targeted_Sequencing_Study
Study
EGAS00001000277
-
46 patients primary malignant glioma cohort in Chinese population
Study
EGAS00001005583
-
Spatial Transcriptomics on prostate cancer heterogeneity
Study
EGAS00001003001
-
Analysis of tumor periphery and center-specific mutations in renal cell carcinoma
Study
EGAS00001001784
-
Whole genome, whole exome, and targeted sequencing of high-grade meningioma tumor samples.
Study
EGAS00001002294
-
BGISEQ-500 Cancer Dataset - WGS tumour/normal pairs
Study
EGAS00001002298
-
Mesothelioma Genomics Study - WGS tumour/normal pairs
Study
EGAS00001002299
-
UK renal cancer samples genotyped on Illumina OmniExpress BeadChip
Study
EGAS00001002336
-
glioblastoma single cell RNAseq
Study
EGAS00001006236
-
THE GENOMIC LANDSCAPE OF ACTINIC KERATOSIS
Study
EGAS00001004243
-
Comprehensive investigation of genome architecture of gastric adenocarcinoma with whole-genome sequencing in the Chinese population.
Study
EGAS00001002404
-
BLUEPRINT DNA Methylation 450K data of mantle cell lymphoma
Study
EGAS00001001637
-
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Study
EGAS00001001653
-
Spatial and Temporal Homogeneity of Driver Mutations in Diffuse Intrinsic Pointine Glioma
Study
EGAS00001001654
-
33 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) had whole exome sequencing performed. Cells were sorted by FACSAria using CD138, CD19 and CD56 to obtain a pure abnormal plasma cell population. Generated somatic variants were compared to a previous study of 463 multiple myeloma patients.
Study
EGAS00001001658
-
Mutational landscape of renal cell carcinoma with venous tumor thrombus
Study
EGAS00001001950
-
Genomics of enteropathy associated T cell lymphoma (EATL)
Study
EGAS00001001954
-
Exome sequence data for germline, primary tumor, and relapse tumor of a transformed non-Hodgkins lymphoma patient with unexpected long-time remission
Study
EGAS00001001973
-
Prognostic relevance of microenvironmental factors CD163 and CD8 combined with EZH2 and chromosome 18 gain in a validation cohort of follicular lymphoma patients of the Lunenburg Lymphoma Biomarker Consortium
Study
EGAS00001002049
-
RNA-sequencing of six Pilocytic astrocytoma tumors
Study
EGAS00001002149
-
miR-200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Study
EGAS00001002184
-
Gene fusion and transcriptomic landscapes of sarcomas
Study
EGAS00001002189
-
An Unusual Genomic Variant of Pancreatic Ductal Adenocarcinoma with an Indolent Clinical Course
Study
EGAS00001002192
-
HDAC inhibitors in synovial sarcoma cells
Study
EGAS00001002637
-
Sequencing of paediatric High Grade Gliomas and DIPG
Study
EGAS00001002314
-
Whole exome sequencing of an invasive diffuse intrinsic pontine glioma sampled from different sites
Study
EGAS00001002326
-
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus.
Study
EGAS00001002334
-
Poly(A) RNA sequencing of hepatocellular carcinoma tumors and their matched noncancerous liver tissues
Study
EGAS00001002337
-
whole genome sequence data of multifocal hepatocellular carcinoma
Study
EGAS00001002338
-
Exome sequencing of pseudomyxoma peritonei
Study
EGAS00001002418
-
Whole genome sequencing identified biomarker of response to PD1 blockade in Natural-killer/T-cell lymphoma
Study
EGAS00001002420
-
Cisplatin increases sensitivity to FGFR inhibition in patient-derived xenograft models of lung squamous cell carcinoma
Study
EGAS00001002423
-
Deep single-cell RNA sequencing data for 12346 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive NSCLC patients
Study
EGAS00001002430
-
The evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion
Study
EGAS00001002432
-
Genomic landscape of Chordoid Glioma
Study
EGAS00001002433
-
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
Study
EGAS00001002443
-
Control samples, breast cancer clinical samples and matched patient-derived tumour xenografts (PDTXs) to develop and test a computational approach to discriminate human and mouse sequences in PDTXs
Study
EGAS00001002445
-
ATRX mutant neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal differentiation.
Study
EGAS00001002507
-
Cell motility and migration as determinants of stem cell efficacy
Study
EGAS00001002478
-
Mutational signatures of aflatoxin
Study
EGAS00001002490
-
Sampling of multi-centric lower grade glioma influences management and provides insight into gliomagenesis
Study
EGAS00001002495
-
Genome-wide expression profiles to compare array-based, RNAseq and NanoString technologies in patients with resected pancreatic ductal carcinoma.
Study
EGAS00001002501
-
Transcriptome sequencing of intravenous leiomyomatosis and uterine myoma
Study
EGAS00001002504
-
Pharmacogenomic landscape of patient-derived cells informs precision oncology therapy
Study
EGAS00001002515
-
Genome-wide genetic and epigenetic dataset of pancreatic acinar cell carcinomas
Study
EGAS00001002533
-
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Study
EGAS00001002538
-
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Study
EGAS00001002559
-
Exome sequencing data from two myelosarcomas
Study
EGAS00001002562
-
Pilot study for Illumina TST170 NGS panel on cutaneous T cell lymphoma samples
Study
EGAS00001002567
-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
Alternative splicing isoforms in patient-derived hepatocellular carcinoma cells
Study
EGAS00001002697
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Study
EGAS00001002707
-
Aggressive genomic features in clinicallyindolent primary HHV8-negative effusion-based lymphoma
Study
EGAS00001002743
-
Defective T-cell expansion in RASGRP1 deficiency
Study
EGAS00001002753
-
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Study
EGAS00001002757
-
Colorectal adenomas and carcinomas NKI-AvL TGO series Gut2009
Study
EGAS00001002758
-
Comprehensive genetic analysis of uveal melanoma heterogeneity during metastatic progression
Study
EGAS00001002761
-
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T-cell lymphomas with hemophagocytic lymphohistiocytic syndrome
Study
EGAS00001002765
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 2).
Study
EGAS00001002771
-
An integrated molecular study of 20 hepatoblastoma pairs using whole genome sequencing and RNA sequencing
Study
EGAS00001002772
-
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Study
EGAS00001002786
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Somatic IL4R Hotspot Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT activation
Study
EGAS00001002796
-
Molecular subtypes of malignant peritoneal mesothelioma
Study
EGAS00001002820
-
Whole exome sequencing of longitudinal samples from a melanoma patient receiving MEK plus CDK4/6 inhibitor therapy.
Study
EGAS00001002846
-
Whole-genome and transcriptome sequencing of tumor-stage mycosis fungoides
Study
EGAS00001002860
-
Targeted exome sequencing of pleomorphic invasive lobular carcinoma (PILC).
Study
EGAS00001002871
-
Foundation Medicine Genomic Data Used to Identify Prognostic Markers and Fusion Genes in Multiple Myeloma
Study
EGAS00001002874
-
Genomic Heterogeneity and the Small Renal Mass
Study
EGAS00001002919
-
SS18-SSX-mediated hijacking of BAF complexes drives synovial sarcoma
Study
EGAS00001002920
-
Colorectal advanced adenomas NKI-AvL TGO COCOS series
Study
EGAS00001002952
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
RNAseq of Follicular Lymphoma
Study
EGAS00001002980
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996